Sign in
ISEE Stock Price, Chart, Stats & News
IVERIC bio, Inc.
Save
5.51B
Market cap
–
Current P/E
–
Forward P/E
ISEE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 5.11% |
ROA | -26.36% |
ROE | -39.26% |
D/E | 0.18x |
Interest coverage ratio | -83.88x |
ISEE valuation
P/E | – |
P/S | – |
P/B | 9.04x |
P/CF | -29.53x |
P/FCF | -33.51x |
P/OCF | -29.53x |
PEG | -0.28x |
EV multiple | -30.64x |
About
IVERIC bio, Inc. is a biopharmaceutical enterprise focused on identifying and advancing innovative therapeutic solutions for eye conditions, with a particular emphasis on age-related and rare inherited retinal diseases (IRDs). A cornerstone of its development pipeline is Zimura, an inhibitor targeting complement factor C5. This compound is currently undergoing investigation for geographic atrophy (GA), a severe form of dry age-related macular degeneration (AMD).
Similar securities
Based on sector and market capitalization
Report issue